APA (7th ed.) Citation

M, W., C, W., YY, L., DJM, N., H, K., S, S., . . . N, S. (2017). Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer. Oncotarget, 8(30), 49275. https://doi.org/10.18632/oncotarget.17568

Chicago Style (17th ed.) Citation

M, Wangpaichitr, et al. "Exploiting ROS and Metabolic Differences to Kill Cisplatin Resistant Lung Cancer." Oncotarget 8, no. 30 (2017): 49275. https://doi.org/10.18632/oncotarget.17568.

MLA (9th ed.) Citation

M, Wangpaichitr, et al. "Exploiting ROS and Metabolic Differences to Kill Cisplatin Resistant Lung Cancer." Oncotarget, vol. 8, no. 30, 2017, p. 49275, https://doi.org/10.18632/oncotarget.17568.